Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
Clinical trial NCT00518206 · COMPLETED
Trial details
- NCT number
- NCT00518206
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-28
- Primary completion
- 2010-01-22
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.